All Stories

  1. Burden of cancer attributable to occupational asbestos exposure in the Americas, 1990–2023: an analysis using the Global Burden of Disease Study 2023

    Article • The Lancet Regional Health - Americas, June 2026, Elsevier

    Kamoru Ademola Adedokun, Dr. Mahmoud Nassar, Dr Shrikant Pawar, Dr Vijay Kumar Chattu, Dr Mamunur Rashid

  2. Editorial: Pharmacodynamic and pharmacokinetic aspects of redox signaling in inflammation-associated damage and diseases

    Article • Frontiers in Physiology, April 2026, Frontiers

    Dr Mamunur Rashid

  3. Impact of fixed phosphorus position on activity of triazole bisphosphonates as geranylgeranyl diphosphate synthase inhibitors

    Article • Bioorganic & Medicinal Chemistry, May 2025, Elsevier

    Dr Mamunur Rashid

  4. Structure-activity relationship of isoprenoid triazole bisphosphonate-based geranylgeranyl diphosphate synthase inhibitors: Effects on pharmacokinetics, biodistribution, and hepatic transporters

    Article • Drug Metabolism and Disposition, March 2025, Elsevier

    Dr Mamunur Rashid

  5. Preclinical pharmacokinetics, absolute bioavailability and dose proportionality evaluation of bioactive phytochemical Withanone in rats

    Article • Bioorganic Chemistry, February 2025, Elsevier

    Dr Mamunur Rashid

  6. Geranylgeranyl diphosphate synthase inhibition impairs osteoclast differentiation, morphology, and resorptive activity

    Article • JBMR Plus, October 2024, Oxford University Press (OUP)

    Dr Mamunur Rashid

  7. Formulation and Characterization of Phytosomes as Drug Delivery System of Formononetin: An Effective Anti-Osteoporotic Agent

    Article • Current Drug Delivery, February 2024, Bentham Science Publishers

    Arun agarwal, Dr Wahajuddin Wahajuddin, Dr Mamunur Rashid, nazneen sultana

  8. Effects of chronic cirrhosis induced by intraperitoneal thioacetamide injection on the protein content and Michaelis–Menten kinetics of cytochrome P450 enzymes in the rat liver microsomes

    Article • Basic & Clinical Pharmacology & Toxicology, November 2022, Wiley

    Dr Mamunur Rashid

  9. Differential expression and activities of cytochrome P450 3A in the rat brain microsomes and mitochondria

    Article • Fundamental and Clinical Pharmacology, November 2022, Wiley

    Dr Mamunur Rashid

  10. Discovery of 2,3-dihydro-1 H -pyrrolo[3,4- b ]quinolin-1-one derivatives as possible antileishmanial agents

    Article • RSC Medicinal Chemistry, January 2022, Royal Society of Chemistry

    Dr Mamunur Rashid

  11. 2,3-Difunctionalized Benzo[b]thiophene Scaffolds Possessing Potent Antiangiogenic Properties

    Article • Journal of Medicinal Chemistry, December 2021, American Chemical Society (ACS)

    Dr Mamunur Rashid

  12. Isoformononetin, a dietary isoflavone protects against streptozotocin induced rat model of neuroinflammation through inhibition of NLRP3/ASC/IL-1 axis activation

    Article • Life Sciences, December 2021, Elsevier

    Dr Mamunur Rashid

  13. Chromatographic separation and estimation of natural antimalarial flavonoids in biological matrices

    Article • Proceedings of the Indian National Science Academy, September 2021, Springer Science + Business Media

    Dr Mamunur Rashid

  14. A novel nanosized phospholipid complex of Biochanin A for improving oral bioavailability: Preparation and in-vitro/in-vivo characterizations

    Article • Journal of Drug Delivery Science and Technology, February 2021, Elsevier

    Dr Mamunur Rashid

  15. Mechanistic exploration of quercetin against metronidazole induced neurotoxicity in rats: Possible role of nitric oxide isoforms and inflammatory cytokines

    Article • NeuroToxicology, July 2020, Elsevier

    Dr Mamunur Rashid

  16. Skeletal restoration by phosphodiesterase 5 inhibitors in osteopenic mice: Evidence of osteoanabolic and osteoangiogenic effects of the drugs

    Article • Bone, June 2020, Elsevier

    Dr Mamunur Rashid

  17. Bioavailability, tissue distribution and excretion studies of a potential anti-osteoporotic agent, medicarpin, in female rats using validated LC–MS/MS method

    Article • Journal of Pharmaceutical and Biomedical Analysis, February 2020, Elsevier

    Dr Mamunur Rashid

  18. β-Amino acid derivatives as mitochondrial complex III inhibitors of L. donovani: A promising chemotype targeting visceral leishmaniasis

    Article • European Journal of Medicinal Chemistry, November 2019, Elsevier

    Dr Mamunur Rashid

  19. LC-ESI-MS/MS method for the simultaneous determination of isoformononetin, daidzein, and equol in rat plasma: Application to a preclinical pharmacokinetic study

    Article • Journal of Chromatography B, October 2019, Elsevier

    Dr Mamunur Rashid

  20. Bioavailability Enhancement of Poorly Soluble Drugs

    Article • Current Pharmaceutical Design, July 2019, Bentham Science Publishers

    Dr Mamunur Rashid

  21. Reversal of Osteopenia in Ovariectomized Rats by Pentoxifylline: Evidence of Osteogenic and Osteo-Angiogenic Roles of the Drug

    Article • Calcified Tissue International, June 2019, Springer Science + Business Media

    Dr Mamunur Rashid

  22. Oral dosing of pentoxifylline, a pan-phosphodiesterase inhibitor restores bone mass and quality in osteopenic rabbits by an osteogenic mechanism: A comparative study with human parathyroid hormone

    Article • Bone, June 2019, Elsevier

    Dr Mamunur Rashid

  23. Synthesis, Biological Evaluation, Structure–Activity Relationship, and Mechanism of Action Studies of Quinoline–Metronidazole Derivatives Against Experimental Visceral Leishmaniasis

    Article • Journal of Medicinal Chemistry, May 2019, American Chemical Society (ACS)

    Dr Mamunur Rashid

  24. Neuropharmacokinetics: a bridging tool between CNS drug development and therapeutic outcome

    Article • Drug Discovery Today, May 2019, Elsevier

    Dr Mamunur Rashid

  25. Novel Tetrahydroquinazolinamines as Selective Histamine 3 Receptor Antagonists for the Treatment of Obesity

    Article • Journal of Medicinal Chemistry, April 2019, American Chemical Society (ACS)

    Dr Mamunur Rashid

  26. Chronic histamine 3 receptor antagonism alleviates depression like conditions in mice via modulation of brain-derived neurotrophic factor and hypothalamus-pituitary adrenal axis

    Article • Psychoneuroendocrinology, March 2019, Elsevier

    Dr Mamunur Rashid

  27. Corrigendum to “Identification of novel β-lactams and pyrrolidinone derivatives as selective Histamine-3 receptor (H3R) modulators as possible anti-obesity agents” [Eur. J. Med. Chem. 152 (2018) 148–159]

    Article • European Journal of Medicinal Chemistry, August 2018, Elsevier

    Dr Mamunur Rashid

  28. Identification of novel β-lactams and pyrrolidinone derivatives as selective Histamine-3 receptor (H3R) modulators as possible anti-obesity agents

    Article • European Journal of Medicinal Chemistry, May 2018, Elsevier

    Dr Mamunur Rashid

  29. Development and validation of UPLC-MS/MS assay for quantification of cladrin: Absolute bioavailability and dose proportionality study in rats

    Article • Journal of Pharmaceutical and Biomedical Analysis, April 2018, Elsevier

    Dr Mamunur Rashid

  30. Species differences between rat and human in vitro metabolite profile, in vivo predicted clearance, CYP450 inhibition and CYP450 isoforms that metabolize benzanthrone: Implications in risk assessment

    Article • Food and Chemical Toxicology, January 2018, Elsevier

    Dr Mamunur Rashid

  31. Therapeutic Targeting of NLRP3 Inflammasomes by Natural Products and Pharmaceuticals: A Novel Mechanistic Approach for Inflammatory Diseases

    Article • Current Medicinal Chemistry, July 2017, Bentham Science Publishers

    Dr Mamunur Rashid

  32. Preparation and in-vitro/in-vivo characterization of trans-resveratrol nanocrystals for oral administration

    Article • Drug Delivery and Translational Research, February 2017, Springer Science + Business Media

    Dr Mamunur Rashid

  33. Bioanalysis of antitubercular drugs using liquid chromatography

    Article • Journal of Pharmaceutical and Biomedical Analysis, February 2017, Elsevier

    Dr Mamunur Rashid

  34. Pharmacological activation of aldehyde dehydrogenase 2 promotes osteoblast differentiation via bone morphogenetic protein-2 and induces bone anabolic effect

    Article • Toxicology and Applied Pharmacology, February 2017, Elsevier

    Dr Mamunur Rashid

  35. Synthesis and Evaluation of Chirally Defined Side Chain Variants of 7-Chloro-4-Aminoquinoline To Overcome Drug Resistance in Malaria Chemotherapy

    Article • Antimicrobial Agents and Chemotherapy, December 2016, ASM Journals

    Dr Mamunur Rashid

  36. Abstract

    Article • Drug Metabolism Reviews, July 2016, Taylor & Francis

    Dr Mamunur Rashid

  37. Comparative assessment of bioanalytical method validation guidelines for pharmaceutical industry

    Article • Journal of Pharmaceutical and Biomedical Analysis, July 2016, Elsevier

    Dr Mamunur Rashid

  38. Pharmacokinetic endeavors for antimalarial therapeutics

    Article • International Journal of Infectious Diseases, April 2016, Elsevier

    Dr Mamunur Rashid

  39. DBS-platform for biomonitoring and toxicokinetics of toxicants: proof of concept using LC-MS/MS analysis of fipronil and its metabolites in blood

    Article • Scientific Reports, March 2016, Springer Science + Business Media

    Dr Mamunur Rashid

  40. No effect on pharmacokinetics of tamoxifen and 4-hydroxytamoxifen by multiple doses of red clover capsule in rats

    Article • Scientific Reports, November 2015, Springer Science + Business Media

    Dr Mamunur Rashid